ATLA :: Alternatives to Laboratory Animals

Volume 35, Number 2
May 2007

CONTENTS

All articles are in PDF Format

EDITORIAL
Time for real action on chimpanzees and other hominids

M. Balls

NEWS & VIEWS

ECVAM NEWS & VIEWS

IIVS NEWS & VIEWS

ARTICLES

Long-term, repeated dose in vitro neurotoxicity of the glutamate receptor antagonist L-AP3, demonstrated in rat hippocampal slice cultures by using continuous propidium iodide incubation
B.W. Kristensen, M. Blaabjerg, J. Noraberg & J. Zimmer

Effects of the introduction of in vitro assays on the use of experimental animals in pharmacological research
P.M. Verbost, J. van der Valk & C.F.M. Hendriksen

The Tubifex tubifex assay for the determination of acute toxicity
M. Tichý, M. Rucki, I. Hanzlíková & Z. Roth

The new EU REACH regulation has finally been adopted: is this the end of the campaign trail...or just the beginning?
C. Grindon

ECVAM WORKSHOP REPORT

Chemical respiratory allergy: opportunities for hazard identification and characterisation
I. Kimber, R. Agius, D.A. Basketter, E. Corsini, P. Cullinan, R.J. Dearman, E. Gimenez-Arnau, L. Greenwell, T. Hartung, F. Kuper, P. Maestrelli, E. Roggen & C. Rovida

COMMENTS

Proposed integrated decision-tree testing strategies for mutagenicity and carcinogenicity in relation to the EU REACH legislation
R. Combes, C. Grindon, M.T.D. Cronin, D.W. Roberts & J. Garrod

Why 'suitable' in vitro methods, as defined in the final EU REACH legislation, are an inappropriate basis for risk assessment
R.D. Combes

CONFERENCE DIARY